4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001583742-15-000001
$ELTPCIK 0001053369operating
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:07 PM ET
Size
10.3 KB
Accession
0001583742-15-000001
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Conversion
Warrants
2015-06-02−1,982,106→ 0 total(indirect: By LLC)Exercise: $0.06From: 2011-03-31Exp: 2018-03-31→ Common Stock (1,982,106 underlying) - Conversion
Common Stock
2015-06-02$0.06/sh+2,741,801$171,363→ 5,311,819 total(indirect: By LLC) - Conversion
Warrants
2015-06-02−759,695→ 0 total(indirect: By LLC)Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (759,695 underlying)
Holdings
- 2,700,000(indirect: By IRA)
Common Stock
- 13,760,695
Common Stock
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:07 PM ET
- Size
- 10.3 KB